Propanc Biopharma Inc.

PPCB | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.91

+$0.07 (+3.80%)

Nov 2, 2026, 9:45 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Jun 30, 2026	FY 2025 Jun 30, 2025	FY 2024 Jun 30, 2024	FY 2023 Jun 30, 2023	FY 2022 Jun 30, 2022	FY 2021 Jun 30, 2021
Net Income	-18.86M	-58.92M	-1.82M	-2.66M	-2.66M	-2.03M
Depreciation & Amortization	22.7K	20.19K	21.66K	22.93K	5.67K	1.99K
Stock-Based Compensation	n/a	4.62M	n/a	n/a	n/a	82.87K
Other Working Capital	-393.81K	952.89K	175.08K	392.22K	146.91K	262.88K
Other Non-Cash Items	13.74M	52.74M	446.34K	1.06M	1.05M	356.77K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-584.94K	1.14M	417.42K	472.59K	167.44K	439.05K
Operating Cash Flow	-5.68M	-405.17K	-935.12K	-1.11M	-1.44M	-1.15M
Capital Expenditures	-4.94K	-2	-2	1	4	4
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-4.93K	n/a	n/a	n/a	n/a	n/a
Debt Repayment	-807.26K	755.41K	918.84K	590.25K	766.5K	282K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-932.25K	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	932.25K	-264.66K	717.01K	498.76K	625K	776.04K
Financial Cash Flow	6.46M	490.76K	941.89K	1.11M	1.49M	1.06M
Net Cash Flow	819.92K	-9K	11.04K	5.98K	1.81K	-64.75K
Free Cash Flow	-5.68M	-405.17K	-935.12K	-1.11M	-1.44M	-1.15M
Adj. Free Cash Flow	-5.68M	-5.03M	-935.12K	-1.11M	-1.44M	-1.23M
Maintenance CapEx	-4.94K	-2	-2	-1	-4	-4
Growth CapEx	n/a	n/a	n/a	2	8	8
Owner Earnings	-5.69M	-405.17K	-935.12K	-1.11M	-1.44M	-1.15M